Genmab A/S's total assets for Q2 2026 were kr12.52B, an increase of 1.22% from the previous quarter. DE:GE9 total liabilities were kr6.56B for the fiscal quarter, a -1.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.